Cargando…

Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor

Pleural effusion (PE) is a common manifestation of tuberculosis (TB) and malignant tumors but tuberculous PE (TPE) is difficult to distinguish from malignant PE (MPE), especially by noninvasive detection indicators. This study aimed to find effective detection indices in blood and PE for differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jian, Feng, Zhe-Xiang, Ren, Tao, Meng, Wei-Yu, Khan, Imran, Fan, Xing-Xing, Pan, Hu-Dan, Liu, Liang, Tang, Yi-Jun, Yao, Xiao-Jun, Li, Run-Ze, Wang, Mei-Fang, Leung, Elaine Lai-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5700 Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575824/ https://www.ncbi.nlm.nih.gov/pubmed/36254028 http://dx.doi.org/10.1097/MD.0000000000031027

Ejemplares similares

Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion
por: Han, Gaohua, et al.
Publicado: (2023)

Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report
por: Jiang, Sujing, et al.
Publicado: (2017)

Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion
por: Qi, Nan, et al.
Publicado: (2016)

GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
por: Liu, Yongxia, et al.
Publicado: (2021)

Pleural small cell carcinoma with massive pleural effusion: A case report
por: Jang, Jong Geol, et al.
Publicado: (2019)

The clinical efficacy of traditional Chinese medicine in the treatment of malignant pleural effusion: A protocol of systematic review and meta-analysis
por: Lin, Zhen, et al.
Publicado: (2020)

Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
por: Tang, Yimin, et al.
Publicado: (2019)

Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
por: Hu, Yongqi, et al.
Publicado: (2022)

Comparison between different treatment regimens of vascular targeting drug to malignant pleural effusion in patients with lung cancer: A Bayesian network meta-analysis
por: Huang, Peng, et al.
Publicado: (2023)

The value of apolipoprotein E in distinguishing benign and malignant unilateral pleural effusions
por: Xue, Qing, et al.
Publicado: (2020)

Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion
por: Gayaf, Mine, et al.
Publicado: (2021)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Distinguishing tuberculosis pleural effusion from parasitic pleural effusion using pleural fluid characteristics: A case control study
por: Tong, Shuai, et al.
Publicado: (2019)

Tislelizumab combined with anlotinib in the second-line treatment of malignant pleural mesothelioma
por: Zhang, Dandan, et al.
Publicado: (2022)

Malignant pleural effusion: Updates in diagnosis, management and current challenges
por: Addala, Dinesh Narayan, et al.
Publicado: (2022)

A detection panel of novel methylated DNA markers for malignant pleural effusion
por: Liang, Chaonan, et al.
Publicado: (2022)

Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study
por: Fei, Guo, et al.
Publicado: (2023)

Confocal Laser Endomicroscopy for Diagnosing Malignant Pleural Effusions
por: Zirlik, Sabine, et al.
Publicado: (2018)

Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
por: Principe, Nicola, et al.
Publicado: (2021)

Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines
por: Song, Qi, et al.
Publicado: (2020)

Total Protein–Chloride Ratio in Pleural Fluid Independently Predicts Overall Survival in Malignant Pleural Effusion at the First Diagnosis
por: Qiao, Xin, et al.
Publicado: (2022)

Score for Differentiating Pleural Tuberculosis from Malignant Effusion
por: González, Alejandra, et al.
Publicado: (2019)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report
por: Rhazari, Meriem, et al.
Publicado: (2022)

Differentiating malignant and benign pleural effusion in patients with lung cancer: an (18)F-FDG PET/CT retrospectively study
por: Zhang, Weishan, et al.
Publicado: (2023)

Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram
por: Wu, Aihua, et al.
Publicado: (2021)

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
por: Xiang, Zhangqiang, et al.
Publicado: (2022)

The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
por: Halimi, Monireh, et al.
Publicado: (2019)

Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
por: Li, Xin, et al.
Publicado: (2022)

Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures Review
por: Jing, Xu-Quan, et al.
Publicado: (2016)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules
por: Sheng, Danli, et al.
Publicado: (2021)

Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023)

The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study
por: Wu, Huimin, et al.
Publicado: (2017)

The perplexing pleura: Diagnosing tuberculosis pleural effusions in the era of drug resistance
por: Shaw, Jane A, et al.
Publicado: (2019)

Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes
por: Wang, Xiaosheng, et al.
Publicado: (2016)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Quality assessment of the guidelines for the management of malignant pleural effusions and ascites
por: Li, Jia-Xi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hd9dqntg4jjoh9aqbf44e9cup7